Abstract
The aim of the present study was to describe a method combining easy implementation in a clinical setting with accuracy and precision in quantification of 123I-labeled N-(3-iodoprop-(2E)-enyl)-2beta-carboxymethoxy-3beta-(4'-methylphenyl)nortropane (PE2I) binding to brain dopamine transporter.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Journal of Nuclear Medicine |
Vol/bind | 46 |
Udgave nummer | 7 |
Sider (fra-til) | 1119-27 |
Antal sider | 9 |
ISSN | 0161-5505 |
Status | Udgivet - 1 jul. 2005 |